Sera Prognostics

Get Full Access

Description

  • Sera Prognostics is a private biotechnology company developing innovative diagnostic tests designed for the early prediction of preterm birth risk and other pregnancy complications. Seras tests are designed to help better inform the care of a mother and her unborn child during pregnancy, and potentially lead to improved health. The company has assembled a strong management team and Board of Directors with significant clinical development and womens healthcare diagnostic experience. The Company is supported by a strong group of investors, including the Bill & Melinda Gates Foundation, Chione, Ltd, Domain Associates, InterWest Partners, Catalyst Health Ventures, UpStart Life Sciences Capital, and Osage University Partners. The Company is working with the Bill & Melinda Gates Foundation to translate its discoveries and develop technologies to benefit women and infants in underserved countries worldwide. Sera Prognostics is located in Salt Lake City, Utah. Sera launched its first diagnostic test in the Spring of 2016. The PreTRM® test is the first and only clinically validated blood test that provides an early and individual risk prediction for spontaneous preterm birth in asymptomatic, singleton pregnancies. The PreTRM test can help physicians identify early in the pregnancy (during weeks 19 and 20 of gestation) which women are at increased risk for early delivery, enabling more informed management decisions based on each womens individual risk. Using proteomic technology, the test measures and analyzes proteins in the blood that are predictive of preterm birth. Better understanding of the proteins expressed in pregnancy may lead to understanding the causes of preterm birth and making further advancements in prolonging gestational age and improving newborn outcomes. For more information about the PreTRM® test, please visit www.PreTRM.com and the PreTRM test YouTube Channel. You can also join the conversation on Facebook and Twitter @PreTRM.
  • location

    Headquarters:2749 East Parleys Way , Salt Lake City, Utah, United States

    More
  • Sera Prognostics phone

    Phone Number: +1 801-990-0520

  • Sera Prognostics website

    Website: seraprognostics.com

  • Sera Prognostics employees

    Employees:57

  • Sera Prognostics revenue

    Revenue:$50 - 100M

  • Sera Prognostics legal name

    Legal Name:Sera Prognostics

  • Sera Prognostics's Social Media

    Sera Prognostics linkedin
  • done Is this data correct?
  • |  NAICS Code: 621511  |

    Show More
Person level website identification

CEO for Sera Prognostics

Gregory Critchfield

Chairman And Chief Executive Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Mike Foley

Chief Medical Officer

Jay Boniface

Chief Scientific Officer

Paul Kearney

Chief Data Officer

Robert Harrison

Chief Information Officer

Jay Moyes

Chief Financial Officer

Frequently Asked Questions regarding Sera Prognostics

  • Where are Sera Prognostics's Headquarters?

    Sera Prognostics's Headquarters are in 2749 East Parleys Way ,Salt Lake City,Utah,United States

  • What is Sera Prognostics's phone number?

    Sera Prognostics's phone number is +1 801-990-0520

  • What is Sera Prognostics's official website?

    Sera Prognostics's official website is seraprognostics.com

  • What is Sera Prognostics's Revenue?

    Sera Prognostics's revenue is $50 - 100M

  • What is Sera Prognostics's NAICS code?

    Sera Prognostics's NAICS code is 621511

  • How many employees are working in Sera Prognostics

    Sera Prognostics has 57 employees

  • What is Sera Prognostics's Industry?

    Sera Prognostics is in the industry of Biotechnology

  • Who is Sera Prognostics's CEO?

    Sera Prognostics's CEO is Gregory Critchfield

Company Directory